CBOE vs CODX · P/E 24, $29.50B cap vs rev $3.9M
Cboe Global Markets Inc (CBOE) versus Co-Diagnostics, Inc. Common Stock (CODX) — a side-by-side from cached financials, not a winner call.
Cboe Global Markets Inc (CBOE) is a financial data & stock exchanges company listed on US.
Co-Diagnostics, Inc. Common Stock (CODX) is a medical devices company listed on US.
CBOE does not have a complete income-statement cache yet.
Latest reported CODX revenue for 2024-12-31 was $3.9M. Net income was -$37.6M. Revenue was down 42.5% from 2023-12-31 to 2024-12-31. CODX currently screens at market cap $31.4M.
CBOE currently screens at market cap $29.50B and trailing P/E 24.1. CODX currently screens at market cap $31.4M.
Not investment advice. Open the CBOE and CODX stock pages for the full models.
Not investment advice.